Key Highlights

  • Ingredion's $0.83 quarterly dividend, up from $0.82, goes ex-dividend October 1, 2026 and is payable October 20 to shareholders.
  • Second-quarter reported EPS was $1.78 versus $2.99, and adjusted EPS, a non-GAAP measure, was $2.82 versus $2.87.
  • Reported operating income was $188 million, down 31%, and adjusted operating income was $258 million, down 5%.
  • Ingredion's 595 pence all-cash offer for Tate & Lyle was accepted by Tate & Lyle's shareholders.

Overview

Ingredion Incorporated's (NYSE:INGR) $0.83 quarterly dividend yields 3.44% and is an increase from $0.82, declared September 17, 2026. Second-quarter reported EPS was $1.78 and adjusted EPS, a non-GAAP measure, was $2.82, and 2026 reported EPS guidance is $9.15 to $9.75. The company's 595 pence all-cash offer for Tate & Lyle was accepted by Tate & Lyle's shareholders.

Dividend Program and Shareholder Returns

Ingredion's board declared a quarterly dividend of $0.83 per share on September 17, 2026, payable October 20 to shareholders of record on October 1. The rate was raised from $0.82, which the company paid in July.

The latest filing identifies no special or supplemental common dividend. Dividend declarations remain subject to board approval and the company's financial condition.

About the Company

Ingredion is a global provider of ingredient solutions to the food and beverage manufacturing industry. Its segments include Texture & Healthful Solutions, Food & Industrial Ingredients in the U.S. and Canada, and Latin America. Results depend on ingredient volumes, pricing, input costs and currency movements.

Financial Performance Behind the Payout

Ingredion reported second-quarter net sales up 1%. Reported operating income was $188 million, down 31%, and adjusted operating income was $258 million, down 5%. Excluding foreign exchange translation, reported operating income was down 32% and adjusted operating income was down 7%.

Reported diluted EPS was $1.78 versus $2.99. Adjusted diluted EPS, a non-GAAP measure, was $2.82 versus $2.87. The reported figure includes a net gain on the sale of a business of $0.27 per share.

Net financing costs were $55 million versus $12 million, which the company attributes mainly to a $47 million mark-to-market foreign exchange loss on derivatives hedging pound sterling exposure tied to the pending Tate & Lyle acquisition. Net capital expenditures were $210 million through June 30.

The Tate & Lyle Offer and the Pakistan Sale Behind the Quarter

Ingredion's 595 pence all-cash offer to acquire Tate & Lyle was accepted by Tate & Lyle's shareholders, and the company has begun integration planning for the pending acquisition. It also sold a majority stake in its Pakistan business, which its half-year summary describes as producing a $44 million gain.

The company reaffirmed amended full-year 2026 guidance reflecting the Pakistan sale. For the first half, net sales were $3.64 billion and adjusted operating income was $470 million, down 14%.

Outlook

Ingredion guides 2026 reported EPS to $9.15 to $9.75 and adjusted EPS to $10.30 to $10.90, with reported operating income down low double digits and adjusted operating income down mid-single digits. The Tate & Lyle acquisition, the Pakistan sale and the financing costs tied to the pound sterling hedges are the other items in its release.